Investor Presentation

Investor Presentation - Q1FY27 - Consolidated revenue grew 21% to 70,435 million INR; EBITDA up 28% to 10,920 million INR; PAT increased 34% to 5,805 million INR - Healthcare Services revenue rose 22% with 13% volume growth; 5 new hospitals commissioned recently - Diagnostics & Retail Health revenue grew 15% YoY; Diagnostics EBITDA surged 136% YoY - Apollo HealthCo revenue increased 22% with 78% PAT growth; digital cash loss reduced significantly - Company targets 250 billion INR annualized revenue run rate by Q4 FY27 with EBITDA margin of 6.5-7.0% - Expansion plans include multiple greenfield and brownfield hospital projects across India - Apollo Children’s Hospital and other units received multiple awards for quality and operational excellence